Clinical Trial Update: Haploidentical Bone Marrow Transplant With Post-Transplant Cyclophosphamide for Patients With Severe Aplastic Anemia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating haploidentical bone marrow transplant with post-transplant cyclophosphamide for severe aplastic anemia, currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: Northside Hospital, Inc. | Conditions: Severe Aplastic Anemia | Phase 2 | Status: RECRUITING